Relationship between multimorbidity treatment burden and chronic disease self-efficacy in the elderly population of China
- PMID: 40248076
- PMCID: PMC12004411
- DOI: 10.3389/fmed.2025.1521189
Relationship between multimorbidity treatment burden and chronic disease self-efficacy in the elderly population of China
Abstract
Objectives: This study aimed to evaluate the risk factors associated with the treatment burden of multimorbidity among older Chinese adults and to investigate the relationship between treatment burden and chronic disease self-efficacy.
Methods: Data for this study were collected from a population-based investigation of individuals aged 60 years and older with at least two chronic diseases, conducted by Wuhan University. A structured questionnaire was employed to collect demographic information, chronic disease status, multimorbidity treatment burden (assessed using the Multimorbidity Treatment Burden Questionnaire, MTBQ), and chronic disease self-efficacy (assessed using the Self-Efficacy for Managing Chronic Disease 6-item scale, SEMCD6). The Pearson chi-square test and logistic regression were used to analyze the data.
Results: A total of 1,599 individuals with a mean age of 71.48 years were enrolled in our study, of whom 13.01% were over 80 years. The proportion of low, medium, and high multimorbidity treatment burden was 30.42, 13.88, and 15.21%, respectively. For elderly individuals; residence; gender; age; high school education experience; comorbidities with stroke, chronic respiratory disease, Parkinson's disease, dementia, psychological disorders; and individuals who had 6 or more chronic diseases were found to be significantly associated with the MTBQ score. A higher MTBQ score was significantly associated with a lower SEMCD6 score.
Conclusion: The findings suggest that lower socioeconomic status and comorbidities with stroke, cognitive diseases, and mental disorders contribute to a higher perceived MTBQ score. Moreover, a higher level of multimorbidity treatment burden may potentially lead to poorer motivation for health management behaviors.
Keywords: chronic disease self-efficacy; chronic diseases; elderly population; multimorbidity; treatment burden.
Copyright © 2025 Guo, Tan, Shi, Bai and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Translation, cultural adaptation and validation of the Chinese Multimorbidity Treatment Burden Questionnaire(C-MTBQ): a study of older hospital patients.Health Qual Life Outcomes. 2020 Jun 22;18(1):194. doi: 10.1186/s12955-020-01395-z. Health Qual Life Outcomes. 2020. PMID: 32571343 Free PMC article.
-
Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ).BMJ Open. 2018 Apr 12;8(4):e019413. doi: 10.1136/bmjopen-2017-019413. BMJ Open. 2018. PMID: 29654011 Free PMC article.
-
Danish validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ) and findings from a population health survey: a mixed-methods study.BMJ Open. 2022 Jan 3;12(1):e055276. doi: 10.1136/bmjopen-2021-055276. BMJ Open. 2022. PMID: 34980626 Free PMC article.
-
Validation of the Lithuanian multimorbidity treatment burden questionnaire (MTBQ) and its association with primary care patient characteristics.Eur J Gen Pract. 2023 Dec;29(1):2284257. doi: 10.1080/13814788.2023.2284257. Epub 2023 Nov 27. Eur J Gen Pract. 2023. PMID: 38010870 Free PMC article.
-
Translation, cross-cultural adaptation and validation of the Arabic multimorbidity treatment burden questionnaire (MTBQ-A): A study of adults with multimorbidity.Res Social Adm Pharm. 2024 Apr;20(4):411-418. doi: 10.1016/j.sapharm.2024.01.001. Epub 2024 Jan 9. Res Social Adm Pharm. 2024. PMID: 38267315
References
LinkOut - more resources
Full Text Sources